Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

2024 — This multi-state study is a real world data analyses of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine. VISION ... Study May Help Boost Performance and ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, ac ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...

If the influenza virus infecting cattle workers starts a pandemic, help in the form of a vaccine is months away ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

2 variant. The spike protein sits on the outside of the coronavirus and is what the virus uses to enter cells. The mRNA vaccines work by prompting the body to temporarily make its own spike ...

There is one polio vaccine approved for use in the United States, called Ipol, that is made with an inactivated (dead) virus. Trade Name Doses Age Route Ipol 4 6 weeks and over IM or SC The live oral ...